The Cigna Group Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
The Cigna Group (CI) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $1.88 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-07-30
- The Cigna Group net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $1.88B, a 14.89% increase year-over-year.
- The Cigna Group net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was $1.86B, a 32.08% increase year-over-year.
- The Cigna Group net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-06-30 was $1.63B, a 0.18% increase year-over-year.
- The Cigna Group net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-03-31 was $1.41B.
- The Cigna Group net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2025 was $6.29B, a 66.44% increase from fiscal 2024.
- The Cigna Group net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2024 was $3.78B, a 27.23% decline from fiscal 2023.
- The Cigna Group net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was $5.19B, a 23.32% decline from fiscal 2022.
- The Cigna Group net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2022 was $6.77B, a 25.37% increase from fiscal 2021.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month as first filed | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month as first filed | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month as first filed | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.88B 10-Q · filed 2026-07-30 | $3.74B 10-Q · filed 2026-07-30 | ||||||
| 2026-03-31 | $1.86B 10-Q · filed 2026-04-30 | |||||||
| 2025-12-31 | $6.29B 10-K · filed 2026-02-26 | |||||||
| 2025-06-30 | $1.63B 10-Q · filed 2026-07-30 | $3.04B 10-Q · filed 2026-07-30 | $4.58B derived: sum of 3 quarters · filed 2026-07-30 | $5.40B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $1.41B 10-Q · filed 2026-04-30 | $2.94B derived: sum of 2 quarters · filed 2026-04-30 | $3.77B derived: sum of 3 quarters · filed 2026-04-30 | $5.40B derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $1.54B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.36B derived: sum of 2 quarters · filed 2026-02-26 | $3.99B derived: sum of 3 quarters · filed 2026-02-26 | $3.78B 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $825.00M 10-Q · filed 2024-10-31 | $2.45B derived: sum of 2 quarters · filed 2024-10-31 | $2.24B 10-Q · filed 2024-10-31 | $3.29B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $1.63B 10-Q · filed 2024-08-01 | $1.42B 10-Q · filed 2024-08-01 | $2.46B derived: sum of 3 quarters · filed 2026-02-26 | $3.87B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$212.00M 10-Q · filed 2024-05-02 | $831.00M derived: sum of 2 quarters · filed 2026-02-26 | $2.24B derived: sum of 3 quarters · filed 2026-02-26 | $3.71B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $1.04B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.46B derived: sum of 2 quarters · filed 2026-02-26 | $3.92B derived: sum of 3 quarters · filed 2026-02-26 | $5.19B 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $1.41B 10-Q · filed 2024-10-31 | $2.88B derived: sum of 2 quarters · filed 2024-10-31 | $4.15B 10-Q · filed 2024-10-31 | $5.37B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $1.47B 10-Q · filed 2024-08-01 | $2.74B 10-Q · filed 2024-08-01 | $3.96B derived: sum of 3 quarters · filed 2025-02-27 | $6.73B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $1.27B 10-Q · filed 2024-05-02 | $2.49B derived: sum of 2 quarters · filed 2025-02-27 | $5.27B derived: sum of 3 quarters · filed 2025-02-27 | $6.83B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $1.22B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.99B derived: sum of 2 quarters · filed 2025-02-27 | $5.56B derived: sum of 3 quarters · filed 2025-02-27 | $6.77B 10-K · filed 2025-02-27 | $6.74B 10-K · filed 2023-02-23 | |||
| 2022-09-30 | $2.77B 10-Q · filed 2023-11-02 | $4.34B derived: sum of 2 quarters · filed 2023-11-02 | $5.55B 10-Q · filed 2023-11-02 | $5.54B 10-Q · filed 2022-11-03 | $6.68B derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $1.57B 10-Q · filed 2023-08-03 | $1.57B 10-Q · filed 2022-08-04 | $2.78B 10-Q · filed 2023-08-03 | $2.77B 10-Q · filed 2022-08-04 | $3.91B derived: sum of 3 quarters · filed 2024-02-29 | $5.54B derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $1.21B 10-Q · filed 2023-05-05 | $1.20B 10-Q · filed 2022-05-06 | $2.34B derived: sum of 2 quarters · filed 2024-02-29 | $3.97B derived: sum of 3 quarters · filed 2024-02-29 | $5.44B derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $1.13B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.76B derived: sum of 2 quarters · filed 2024-02-29 | $4.24B derived: sum of 3 quarters · filed 2024-02-29 | $5.40B 10-K · filed 2024-02-29 | $5.40B 10-K · filed 2022-02-24 | |||
| 2021-09-30 | $1.63B 10-Q · filed 2022-11-03 | $3.10B derived: sum of 2 quarters · filed 2022-11-03 | $4.27B 10-Q · filed 2022-11-03 | $8.41B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $1.47B 10-Q · filed 2022-08-04 | $2.64B 10-Q · filed 2022-08-04 | $6.78B derived: sum of 3 quarters · filed 2023-02-23 | $8.17B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $1.17B 10-Q · filed 2022-05-06 | $5.31B derived: sum of 2 quarters · filed 2023-02-23 | $6.70B derived: sum of 3 quarters · filed 2023-02-23 | $8.46B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $4.14B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $5.53B derived: sum of 2 quarters · filed 2023-02-23 | $7.29B derived: sum of 3 quarters · filed 2023-02-23 | $8.47B 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | $1.39B 10-Q · filed 2021-11-04 | $3.15B derived: sum of 2 quarters · filed 2021-11-04 | $4.33B 10-Q · filed 2021-11-04 | $5.32B derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $1.76B 10-Q · filed 2021-08-05 | $2.94B 10-Q · filed 2021-08-05 | $3.92B derived: sum of 3 quarters · filed 2022-02-24 | $5.27B derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $1.19B 10-Q · filed 2021-05-07 | $2.17B derived: sum of 2 quarters · filed 2022-02-24 | $3.52B derived: sum of 3 quarters · filed 2022-02-24 | $4.92B derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $981.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $2.33B derived: sum of 2 quarters · filed 2022-02-24 | $3.74B derived: sum of 3 quarters · filed 2022-02-24 | $5.11B 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $1.35B 10-Q · filed 2020-11-05 | $2.76B derived: sum of 2 quarters · filed 2020-11-05 | $4.13B 10-Q · filed 2020-11-05 | $4.27B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $1.41B 10-Q · filed 2020-08-06 | $2.78B 10-Q · filed 2020-08-06 | $2.92B derived: sum of 3 quarters · filed 2021-02-25 | $3.69B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $1.37B 10-Q · filed 2020-05-07 | $1.51B derived: sum of 2 quarters · filed 2021-02-25 | $2.29B derived: sum of 3 quarters · filed 2021-02-25 | $3.09B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $144.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $916.00M derived: sum of 2 quarters · filed 2021-02-25 | $1.72B derived: sum of 3 quarters · filed 2021-02-25 | $2.64B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $772.00M 10-Q · filed 2019-10-31 | $1.58B derived: sum of 2 quarters · filed 2019-10-31 | $2.49B 10-Q · filed 2019-10-31 | |||||
| 2018-06-30 | $806.00M 10-Q · filed 2019-08-01 | $1.72B 10-Q · filed 2019-08-01 | ||||||
| 2018-03-31 | $915.00M 10-Q · filed 2019-05-02 | |||||||
| 2017-12-31 | $2.23B 10-K · filed 2020-02-27 | |||||||
| 2016-12-31 | $1.85B 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |